43761 (2024). Ingrid Leary to the Minister for Mental Health

Written Question

Published date: 29 Jul 2024

Metadata

Document type:	Written Question
Parliament number:	54
Question number:	43761 (2024)
Question asked:	14 Jul 2024
Member asking:	Ingrid Leary
Portfolio:	Minister for Mental Health
Minister replying:	Hon Matt Doocey
Answer received:	23 Jul 2024
Status:	Question Answered
Reply type:	Reply
Document ID:	WQ_43761_2024
Document guid:	3d88f1fd-b5ae-4164-81b3-361eec8386e8

43761 (2024). Ingrid Leary to the Minister for Mental Health: Does the Minister agree with Ministry of Health report Evidence Synthesis of the Research on Suicide Prevention and Postvention: Aotearoa New Zealand and International Perspectives (June 2023) that New Zealand should pursue stronger restrictions in access to paracetamol (number of tablets in a pack, number of packs which can be purchased, pharmacy only sales), salicylates, dextropropoxyphene, barbiturates, and caffeine tablets, opioids with appropriate monitoring of the impact of such changes; if so, what, if anything, will the Minister do to address this?

Hon Matt Doocey: I refer the member to question 43752 (2024).